Test-Retest Reliability of the German Version of the Headache Disability Questionnaire (HDQ).

Headache Disorders Clinical Trial

Official title:

Translation, Trans-cultural Adaptations and Test-retest Reliability of the Headache Disability Questionnaire (HDQ)

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04877561
• Other study ID #: ZUAS HDQ
• Status: Not yet recruiting
• Start date: June 1, 2021
• Est. completion date: September 30, 2022

Study information

• Verified date: May 2021
• Source: Zurich University of Applied Sciences
• Contact: Markus J Ernst, Master
• Phone: +41 58 9346448
• Email: markus.ernst[@]zhaw.ch
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

a translated and cultural adapted version of the HDQ will be tested on two occasions with headache patients who are currently in physiotherapeutic treatment due to their headache condition

Description:

The test-retest reliability of the German version of the HDQ will be tested to assess the reproducibility of the test results with a stable condition of the participants over a short period of time. For this purpose, it is planned to administer the questionnaire twice in row at an interval of 48 - 72 hours to headache patients in outpatient physiotherapy. The chosen setting limits the sample to a common intervention measure (physiotherapy), so that primary and secondary headache types can be included and the requirements of the original study can be maintained. In the period between the two tests, subjects should not receive physiotherapy, because it can often have different effects on headache. This can lead to uneven changes in the sample and affect the variance of the test results. However, subjects are allowed to take their usual medications. To avoid recall bias, an online survey tool (RedCAP) to conduct the questionnaire will be used. It is designed so that, only one question appears per slide, no overview of responses is allowed and the questions are displayed in a different order at the second testing. The lower prevalence of headaches after the age of 65 years is taken into account in the inclusion criteria.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: September 30, 2022
• Est. primary completion date: July 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• within physiotherapeutic care due to headache for no longer than 3 months

• headache conditions for at least one month and at least once /month

• live in Switzerland

• give informed consent

Exclusion Criteria:

• not in physiotherapeutic care

• in physiotherapeutic care due to other conditions not associated with headache

• younger than 18 and older than 65 years

Related Conditions & MeSH terms

• Headache
• Headache Disorders

Locations

Country	Name	City	State
Switzerland	Zurich University of Applied Sciences	Winterthur	Zurich

Sponsors (1)

Lead Sponsor	Collaborator
Zurich University of Applied Sciences

Country where clinical trial is conducted

Switzerland, 

References & Publications (5)

Benz T, Lehmann S, Gantenbein AR, Sandor PS, Stewart WF, Elfering A, Aeschlimann AG, Angst F. Translation, cross-cultural adaptation and reliability of the German version of the migraine disability assessment (MIDAS) questionnaire. Health Qual Life Outcomes. 2018 Mar 9;16(1):42. doi: 10.1186/s12955-018-0871-5. — View Citation

Luedtke K, Basener A, Bedei S, Castien R, Chaibi A, Falla D, Fernández-de-Las-Peñas C, Gustafsson M, Hall T, Jull G, Kropp P, Madsen BK, Schaefer B, Seng E, Steen C, Tuchin P, von Piekartz H, Wollesen B. Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study. BMJ Open. 2020 Feb 12;10(2):e029855. doi: 10.1136/bmjopen-2019-029855. — View Citation

Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol. 2003 Aug;56(8):730-5. — View Citation

Niere K, Quin A. Development of a headache-specific disability questionnaire for patients attending physiotherapy. Man Ther. 2009 Feb;14(1):45-51. Epub 2007 Nov 7. — View Citation

Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010 Aug;11(4):289-99. doi: 10.1007/s10194-010-0217-0. Epub 2010 May 16. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Headache	Nine item headache disability questionnaire (HDQ)	June 21 to July 22
Secondary	Headache disorder	Migraine, Tension-type headache, other	June 21 to July 22